Matinas BioPharma Holdings CEO Jerome Jabbour's 2021 pay jumps 26% to $3.7M
Matinas BioPharma Holdings reports 2021 executive compensation
By ExecPay News
Published: September 22, 2022
Matinas BioPharma Holdings reported fiscal year 2021 executive compensation information on September 22, 2022.
In 2021, three executives at Matinas BioPharma Holdings received on average a compensation package of $2.2M, a 14% increase compared to previous year.
Average pay of disclosed executives at Matinas BioPharma Holdings
Jerome D. Jabbour, Chief Executive Officer, received $3.7M in total, which increased by 26% compared to 2020. 78% of Jabbour's compensation, or $2.9M, was in option awards. Jabbour also received $250K in bonus and $545K in salary.
James J. Ferguson, Chief Medical Officer, received a compensation package of $1.6M, which decreased by 2% compared to previous year. 64% of the compensation package, or $1M, was in option awards.
Theresa Matkovits, Chief Development Officer, earned $1.3M in 2021, a 7% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on September 22, 2022.